ARCHIVES

NCAB Committee Ok’s Recompetition of OD Support Contract

This article is from The Cancer Letter archive.

Vol. 18 No. 21 | May 22, 1992

Download PDF Visit The Full Archive

Related Articles

Also in this 8-page issue: Richard Pazdur named director of FDA’s new Office of Oncology Drug Products.

April 22, 2005

Phase III Trial Would Give Clearer Picture Of C225 Role.

February 15, 2002

Broder Explains Where R01 Money Has Gone

July 20, 1990

Dingell: “Unable To Vouch” For Staff Report On NCI’s Gallo

February 10, 1995

CCOPS Unhappy With NCI Policy Limiting Their Participation In Early Phase 2 Clinical Trials

November 11, 1983

CTEP Drafts FDA Approval Guidelines

March 4, 1988